PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 20260 citationsOpen Access

Single Case Study Evaluating the Role of Pathyadi Shadanga Kwatha in Ardhavabhedaka with Special Reference to Migraine.

View Full Paper
MMMuskan MauryaNSNitin SharmaRNRachna Nigam

Key Points

  • This study aims to evaluate the effects of Pathyadi Shadanga Kwatha on migraine symptoms in a specific case.
  • Conducted a case study with a 45-year-old female patient.
  • Administered Pathyadi Shadanga Kwatha at a dose of 50 ml twice daily for 14 days.
  • Monitored headache frequency and severity, along with accompanying symptoms.
  • The patient reported a reduction in headache symptoms.
  • Frequency of headaches decreased significantly.
  • Complete resolution of symptoms was observed during follow-up.

Abstract

Rapid urbanization has altered people’s lifestyles in the modern era. Stress is making acute and chronic disorders like Ardhavabhedaka more common as a result of lifestyle changes. Ardhavabhedaka (Migraine) is a condition associated with moderate to severe headaches with a throbbing type of pain that lasts from hours to days. Usually accompanied by symptoms like nausea and vomiting , fatigue and occasionally giddiness, it starts on one side of the head and spreads to both temporal and occipital regions1,4,5,6. Ardhavabhedaka can be correlated with migraine, due to its cardinal features of a half-sided headache. According to Acharya Charaka , Ardhavabhedaka have Vata-Kapha dosha1,5. The management of these dosha can be done through Pathyadi shadanga kwatha. METHOD- The chief complaint of a 45 year old female patient was that she had been experiencing unilateral headache on and off three times a month, occasionally more than three times ,for the past four year. Headache alternate between occurring on the right and left side occasionaly followed by nausea and vomiting. The patient was treated with Pathyadi shadanga kwatha in a dose of 50 ml twice a day ,which will be continued for 14 days. RESULT-The patient experienced a reduction in headache symptoms and frequency, followed by complete resolution of symptoms during follow-up observations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Maurya et al. (2026) studied this question.

synapsesocial.com/papers/698828b90fc35cd7a8848663https://doi.org/10.5281/zenodo.18503559
Ask AI
Helpful
Bookmark
Share
View Full Paper